T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STMP
1051
DELISTED
Stamps.com, Inc.
STMP
| $43.5M | ﹤0.01% |
217,844
-5,526
| -2% | -$1.18M |
|
|
DRNA
1052
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $43.3M | ﹤0.01% |
1,693,182
-379,035
| -18% | -$9.68M |
|
1053
Grocery Outlet
GO
$1.07B
| $43.3M | ﹤0.01% |
1,172,549
+14,140
| +1% | +$549K |
|
1054
Enanta Pharmaceuticals
ENTA
$393M
| $42.6M | ﹤0.01% |
864,261
-97,184
| -10% | -$4.85M |
|
1055
CBRE Group
CBRE
$42.7B
| $42.6M | ﹤0.01% |
538,339
-32,271
| -6% | -$2.28M |
|
1056
Ally Financial
ALLY
$13.6B
| $42.6M | ﹤0.01% |
941,563
-5,474,778
| -85% | -$229M |
|
|
MRO
1057
DELISTED
Marathon Oil Corporation
MRO
| $42.5M | ﹤0.01% |
3,980,873
+2,677,314
| +205% | +$25.8M |
|
1058
Addus HomeCare
ADUS
$2.2B
| $42.4M | ﹤0.01% |
405,587
-7,409
| -2% | -$844K |
|
1059
Ingevity
NGVT
$2.62B
| $42.2M | ﹤0.01% |
558,691
-60,707
| -10% | -$4.42M |
|
1060
W.P. Carey
WPC
$16.1B
| $42.2M | ﹤0.01% |
608,770
+247,259
| +68% | +$16.6M |
|
1061
Best Buy
BBY
$18B
| $42.1M | ﹤0.01% |
367,109
-23,590
| -6% | -$2.64M |
|
|
CMD
1062
DELISTED
Cantel Medical Corporation
CMD
| $42M | ﹤0.01% |
526,211
-15,991
| -3% | -$1.25M |
|
1063
American Vanguard Corp
AVD
$64M
| $41.9M | ﹤0.01% |
2,054,950
-3,682
| -0.2% | -$70.1K |
|
1064
Design Therapeutics
DSGN
$901M
| $41.9M | ﹤0.01% |
+1,435,254
| New | +$48.4M |
|
1065
Lindsay Corp
LNN
$1.18B
| $41.9M | ﹤0.01% |
251,553
+47,190
| +23% | +$7.32M |
|
1066
Insteel Industries
IIIN
$635M
| $41.6M | ﹤0.01% |
1,348,136
+7,099
| +0.5% | +$212K |
|
1067
Bio-Rad Laboratories Class A
BIO
$9.68B
| $41.5M | ﹤0.01% |
72,670
+36,163
| +99% | +$21.4M |
|
1068
Hain Celestial
HAIN
$53.9M
| $41.3M | ﹤0.01% |
948,381
+74,680
| +9% | +$3.17M |
|
1069
OSI Systems
OSIS
$3.82B
| $41.2M | ﹤0.01% |
428,991
-48,798
| -10% | -$4.63M |
|
|
HBMD
1070
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $41.2M | ﹤0.01% |
2,504,998
-9,320
| -0.4% | -$133K |
|
1071
Commault Systems
CVLT
$6.26B
| $41.2M | ﹤0.01% |
638,389
-9,611
| -1% | -$611K |
|
|
REGI
1072
DELISTED
Renewable Energy Group, Inc.
REGI
| $41M | ﹤0.01% |
620,194
-10,929
| -2% | -$937K |
|
1073
Federal Realty Investment Trust
FRT
$10.2B
| $40.9M | ﹤0.01% |
403,384
-79,340
| -16% | -$7.65M |
|
1074
Diodes
DIOD
$4.48B
| $40.9M | ﹤0.01% |
511,960
+482,895
| +1,661% | +$38.2M |
|
1075
Sphere Entertainment
SPHR
$6.33B
| $40.8M | ﹤0.01% |
499,212
+154,571
| +45% | +$15.4M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.